Azocine, 1,2,3,4,7,8-hexahydro-5-(5-pyrimidinyl)- manufacturers
- TC299423
-
- $1520.00
-
2026-05-11
- CAS:1975146-56-5
- Purity:
- Supply Ability: 10g
|
| | Azocine, 1,2,3,4,7,8-hexahydro-5-(5-pyrimidinyl)- Basic information |
| Product Name: | Azocine, 1,2,3,4,7,8-hexahydro-5-(5-pyrimidinyl)- | | Synonyms: | Azocine, 1,2,3,4,7,8-hexahydro-5-(5-pyrimidinyl)-;TC299423 | | CAS: | 1975146-56-5 | | MF: | C11H15N3 | | MW: | 189.26 | | EINECS: | | | Product Categories: | | | Mol File: | 1975146-56-5.mol |  |
| | Azocine, 1,2,3,4,7,8-hexahydro-5-(5-pyrimidinyl)- Chemical Properties |
| Boiling point | 329.8±42.0 °C(Predicted) | | density | 1.052±0.06 g/cm3(Predicted) | | pka | 10.27±0.40(Predicted) |
| | Azocine, 1,2,3,4,7,8-hexahydro-5-(5-pyrimidinyl)- Usage And Synthesis |
| Description | TC299423 is a novel agonist for nicotinic acetylcholine receptors (nAChRs). TC299423 modestly selectively targets α6β2 subtype. | | Uses | TC299423 is an orally active, brain-penetrant, selective and potent agonist for α6β2 and α4β2 nicotinic acetylcholine receptors (nAChRs) with anxiolytic and antinociceptive properties. TC299423 acts primarily through α6β2 nAChRs that are implicated in the anxiolytic effects of nicotine. TC299423 elicits reward-related behavior mediated through α6β2 nAChRs in hypersensitive α6L90’S mice. TC299423 elicits dopamine release and dose not suppress nicotine self-administration in rats. TC299423 is proming for rasearch of addiction and Parkinson’s disease[1][2]. | | References | [1] Wall TR, et al. TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors. Front Pharmacol. 2017 Sep 26;8:641. DOI:10.3389/fphar.2017.00641
[2] Post M R. Agonist Binding Studies at Two Subtypes of the Nicotinic Acetylcholine Receptor Involved in Parkinson’s Disease and Addiction[D]. California Institute of Technology, 2016. |
| | Azocine, 1,2,3,4,7,8-hexahydro-5-(5-pyrimidinyl)- Preparation Products And Raw materials |
|